Intérêt d'une polychimiothérapie dans le lymphome B intravasculaire = Interest of an intensive chemotherapy for intravascular large B cell lymphomaBALDOLLI, Aurélie; CHUFFART, Marie; GEFFRAY, Loik et al.Bulletin du cancer. 2013, Vol 100, Num 4, pp 317-321, issn 0007-4551, 5 p.Article

Hematogones: a new prognostic factor for acute myeloblastic leukemiaCHANTEPIE, Sylvain P; SALAÜN, Veronique; PARIENTI, Jean-Jacques et al.Blood. 2011, Vol 117, Num 4, pp 1315-1318, issn 0006-4971, 4 p.Article

Nodular, Lymphocyte-Predominant Hodgkin Lymphoma: A Long-Term Study and Analysis of Transformation to Diffuse Large B-Cell Lymphoma in a Cohort of 164 Patients From the Adult Lymphoma Study GroupBIASOLI, Irene; STAMATOULLAS, Aspasia; MEIGNIN, Véronique et al.Cancer. 2010, Vol 116, Num 3, pp 631-639, issn 0008-543X, 9 p.Article

Skin manifestations in CD4+, CD56+ malignanciesPENVEN, Katell; MACRO, Margaret; SALAÜN, Véronique et al.EJD. European journal of dermatology. 2003, Vol 13, Num 2, pp 161-165, issn 1167-1122, 5 p.Article

A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 studyHUNAULT-BERGER, Mathilde; LEGUAY, Thibaut; LAROSA, Fabrice et al.Haematologica (Roma). 2011, Vol 96, Num 2, pp 245-252, issn 0390-6078, 8 p.Article

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL studyABDELALI, Raouf Ben; ASNAFI, Vahid; ESCOFFRE-BARBE, Martine et al.Blood. 2011, Vol 118, Num 19, pp 5099-5107, issn 0006-4971, 9 p.Article

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 studyCASTAIGNE, Sylvie; PAUTAS, Cécile; DE REVEL, Thierry et al.Lancet (British edition). 2012, Vol 379, Num 9825, pp 1508-1516, issn 0140-6736, 9 p.Article

Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: A Phase 1/2 study of the Acute Leukemia French AssociationFARHAT, Hassan; REMAN, Oumedaly; DOMBRET, Hervé et al.American journal of hematology. 2012, Vol 87, Num 1, pp 62-65, issn 0361-8609, 4 p.Article

Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy : results of the multicenter randomized acute Leukemia French Association (ALFA) 9803 trialGARDIN, Claude; TURLURE, Pascal; BOURHIS, Jean-Henri et al.Blood. 2007, Vol 109, Num 12, pp 5129-5135, issn 0006-4971, 7 p.Article

Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 studyTHOMAS, Xavier; ELHAMRI, Mohamed; CHELGHOUM, Youcef et al.Blood. 2011, Vol 118, Num 7, pp 1754-1762, issn 0006-4971, 9 p.Article

Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 casesBAREAU, Benoit; REY, Jérôme; LAMY, Thierry et al.Haematologica (Roma). 2010, Vol 95, Num 9, pp 1534-1541, issn 0390-6078, 8 p.Article

Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association GroupBOISSEL, Nicolas; NIBOUREL, Olivier; HUCHETTE, Pascal et al.Journal of clinical oncology. 2010, Vol 28, Num 23, pp 3717-3723, issn 0732-183X, 7 p.Article

Outcome of treatment in adults with acute lymphoblastic leukemia: Analysis of the LALA-94 trialTHOMAS, Xavier; BOIRON, Jean-Michel; STAMATOULLAS, Aspasia et al.Journal of clinical oncology. 2004, Vol 22, Num 20, pp 4075-4086, issn 0732-183X, 12 p.Article

NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL) : a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) studyASNAFI, Vahid; BUZYN, Agnès; TURLURE, Pascal et al.Blood. 2009, Vol 113, Num 17, pp 3918-3924, issn 0006-4971, 7 p.Article

Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia : a LALA-94 studyASNAFI, Vahid; BUZYN, Agnes; FIERE, Denis et al.Blood. 2005, Vol 105, Num 8, pp 3072-3078, issn 0006-4971, 7 p.Article

Randomized Study of Intensified Anthracycline Doses for Induction and Recombinant Interleukin-2 for Maintenance in Patients With Acute Myeloid Leukemia Age 50 to 70 Years: Results of the ALFA-9801 StudyPAUTAS, Cecile; MERABET, Fatiha; DE REVEL, Thierry et al.Journal of clinical oncology. 2010, Vol 28, Num 5, pp 808-814, issn 0732-183X, 7 p.Article

The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplicationRENNEVILLE, Aline; BOISSEL, Nicolas; GARDIN, Claude et al.Blood. 2009, Vol 113, Num 21, pp 5090-5093, issn 0006-4971, 4 p.Article

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia : results of the GRAAPH-2003 studyDE LABARTHE, Adrienne; ROUSSELOT, Philippe; BUZYN, Agnès et al.Blood. 2007, Vol 109, Num 4, pp 1408-1413, issn 0006-4971, 6 p.Article

Secondary or Concomitant Neoplasms Among Adults Diagnosed With Acute Lymphoblastic Leukemia and Treated According to the LALA-87 and LALA-94 TrialsTAVERNIER, Emmanuelle; LE, Quoc-Hung; DE BOTTON, Stéphane et al.Cancer. 2007, Vol 110, Num 12, pp 2747-2755, issn 0008-543X, 9 p.Article

Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma : A study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)FERME, Christophe; MOUNIER, Nicolas; REMAN, Oumedaly et al.Blood. 2006, Vol 107, Num 12, pp 4636-4642, issn 0006-4971, 7 p.Article

Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: Results of the groupe d'études des lymphomes de l'adulte H89 trialFERME, Christophe; MOUNIER, Nicolas; BERGER, Francoise et al.Journal of clinical oncology. 2002, Vol 20, Num 2, pp 467-475, issn 0732-183XArticle

Factors predictive of early death in patients receiving high-dose CHP (ACVB regimen) for aggressive non-Hodgkin's lymphoma: a GELA studyDUMONTET, Charles; MOUNIER, Nicolas; REYES, Felix et al.British journal of haematology. 2002, Vol 118, Num 1, pp 210-217, issn 0007-1048Article

Chemotherapy plus involved-field radiation in early-stage Hodgkin's diseaseFERME, Christophe; EGHBALI, Houchingue; LEDERLIN, Pierre et al.The New England journal of medicine. 2007, Vol 357, Num 19, pp 1916-1927, issn 0028-4793, 12 p.Article